Cleared+
News
LEIDOS BIOMEDICAL RESEARCH INC received a new award graphicView LEIDOS BIOMEDICAL RESEARCH INC
News2 min read

LEIDOS BIOMEDICAL RESEARCH INC Receives New NIH NCI Award in Frederick, MD

New Federal Award

LEIDOS BIOMEDICAL RESEARCH INC received a new award from the Department of Health and Human Services. The NIH NCI office issued the award identified as 75N91026F00024.

Obligated Amount

The award 75N91026F00024 carries an obligated amount of $1.3M. LEIDOS BIOMEDICAL RESEARCH INC will perform work under this Department of Health and Human Services contract in Frederick, MD.

Award Timeline

The award date for 75N91026F00024 is September 10, 2026. The start date for LEIDOS BIOMEDICAL RESEARCH INC work is September 21, 2026. Performance under the NIH NCI award extends through an end date of September 20, 2031.

Performance Location

LEIDOS BIOMEDICAL RESEARCH INC will carry out work in Frederick, MD. The $1.3M obligated amount supports the company's performance in Frederick, MD, under the Department of Health and Human Services award.

Parent Vehicle

The award 75N91026F00024 falls under parent vehicle 75N91019D00024. LEIDOS BIOMEDICAL RESEARCH INC holds this new award from the NIH NCI office through the parent identifier 75N91019D00024.

Work Period

The five-year performance period for 75N91026F00024 begins September 21, 2026, and runs through September 20, 2031. LEIDOS BIOMEDICAL RESEARCH INC will perform this Department of Health and Human Services work in Frederick, MD, throughout the period.

Cleared professionals tracking LEIDOS BIOMEDICAL RESEARCH INC may see continued work with the NIH NCI office in Frederick, MD.

Contract Details

Event
New award
PIID
75N91026F00024
Parent IDV
75N91019D00024
Agency
Department of Health and Human Services
Office
NIH NCI
Obligated amount
$1.3M
Award date
2026-09-10
Start date
2026-09-21
End date
2031-09-20
Place of performance
FREDERICK, MD

Stay updated

Weekly career intelligence for cleared professionals — hidden-gem small businesses to mission-driven primes.